Company: LDDD
Filing Date: 2025-09-26
Form Type: 10-K
Source: 0001213900-25-091988
Chunk: 245

Company: Longduoduo Co Ltd
Filing Date: 2025-09-26
Form: 10-K
Item: Item 2
Chunk 245
---
 For the Years Ended June 30,  
    Change 

    2025  
    2024  
    $  
    % 
  
    Total revenue 
    $4,262,663  
    $7,389,842  
    $(3,127,179) 
     (42)%
  
    Cost of revenue 
     91,099  
     173,349  
     (82,250) 
     (47)%
  
    Gross Profit 
     4,171,564  
     7,216,493  
     (3,044,929) 
     (42)%

    Total operating expenses 
     3,618,885  
     5,190,352  
     (1,571,467) 
     (30)%
  
    Income from operations 
     552,679  
     2,026,141  
     (1,473,462) 
     (73)%
  
    Other income (expense) 
     161,849  
     (139,656) 
     301,505  
     (216)%
  
    Income before income taxes 
     714,528  
     1,886,485  
     (1,171,957) 
     (62)%
  
    Income taxes 
     222,268  
     523,207  
     (300,939) 
     (58)%
  
    Net income 
     492,260  
     1,363,278  
     (871,018) 
     (64)%

During
the year ended June 30, 2025, our total revenue was $4,262,663, of which $120,866 was attributable to the sale of healthcare services,
primarily derived from sales of “Immunological Ozonated Autohemotherapy”, “Meridian-regulating and Consciousness-restoring
Iatrotechnics”, “Assay”, “PRP” and other healthcare services. The remaining $4,141,797 of revenue was attributable
to commissions earned by the Company from its service as sales agent for Honghai. In June of 2023, the Company began to engage in the
sales agent business and focused on the sales of preventive healthcare solutions administered by Honghai, with